165 results on '"Broering R"'
Search Results
2. Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infection
3. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen
4. Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment
5. MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver
6. Hippo signaling counter regulates early innate immunity in hepatocytes exposed to Hepatitis B virus
7. Hepatitis B virus particles activate toll-like receptor 2 signaling initial upon infection of primary human hepatocytes
8. The Hippo signalling is induced by Toll-like receptor 4 activation and regulatory balance innate immune responses in liver cells
9. Hepatitis B virus entry in primary human hepatocytes initiates toll-like receptor 2-dependent immune signaling
10. Hepatic expression of oncogenes Bmi1 and Dkk1 can be induced by treatment with hepatitis B virus particles or Lipopolysaccharide in vitro and is up-regulated in liver biopsies of patients with chronic HBV infection
11. Hepatitis B virus activates toll-like receptor 2 signaling in primary human hepatocytes
12. Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice in vivo and can be induced by treatment with HBV particles or lipopolysaccharides in vitro
13. Hepatitis B Virus Activates Toll-Like Receptor 2 Signaling upon Infection of Primary Human Hepatocytes
14. Nucleic Acid-Based Polymers Effective against Hepatitis B Virus Infection in Patients Do Not Harbour Immune Stimulatory Properties in Primary Isolated Blood or Liver Cells
15. Poly I:C-stimulated human non-parenchymal liver cells are potent suppressors of hepatitis C virus replication
16. Amphipathic, nucleic acid-based polymers optimized to treat hepatitis B virus infection in patients do not harbour immune stimulatory properties in primary isolated blood or liver cells
17. SAT-414 - Hepatitis B virus entry in primary human hepatocytes initiates toll-like receptor 2-dependent immune signaling
18. LP45 : The hepatitis B virus (HBV) surface antigen impedes hepadnaviral replication-dependent interferon responses in a HBV transgenic mouse model
19. P0705 : Antiviral activity of human non-parenchymal liver cells is restricted to toll-like receptor 3 and involves type I interferons
20. P0696 : Proteasome subunit alpha type-6 regulates the expression of proviral host genes in hepatitis C virus infection
21. Proteasome subunit alpha type-6 regulates the expression of proviral host genes in hepatitis C virus infection
22. All-In-One: Advanced human parenchymal and non-parenchymal liver cell preparation
23. Hepadnaviral replication in HBV-transgenic mice lacking the surface antigen (HBsAg) is controlled by toll-like receptor 3-induced immune responses
24. P150 INTERFERON-STIMULATED GENE 15, A PROVIRAL FACTOR FOR HEPATITIS C VIRUS, AND PROTEASOME SUBUNIT ALPHA TYPE-6 ARE INDUCED BY POLY(I:C) AND RECIPROCALLY AFFECT EACH OTHER
25. P218 TOLL-LIKE RECEPTOR 3 STIMULATION OF HUMAN NON-PARENCHYMAL LIVER CELLS TRIGGERS AN ANTIVIRAL STATE AGAINST HCV WHICH IS NOT EXCLUSIVELY MEDIATED BY TYPE-I OR TYPE-III IFNS
26. P151 HEPADNAVIRAL REPLICATION IN HBV-TRANSGENIC MICE LACKING THE SURFACE ANTIGEN IS ACCOMPANIED BY TOLL-LIKE RECEPTOR 3 MEDIATED INTERFERON RESPONSES
27. Human non-parenchymal liver cells produce type I and type III interferons in response to poly I:C, thereby mediating an antiviral state against HCV
28. Toll-like receptor 3 activation mediates the expression of interferon and interferon stimulated genes during hepadnaviral replication in HBV-transgenic mice lacking the HBs-antigen
29. Interferon stimulated gene 15, a proviral factor in hepatitis C virus replication, is regulated by the Proteasome subunit alpha type-6
30. KIR2DL3+ NKG2A- Natural Killer Cells Protect People who Inject Drugs against Productive Hepatitis C Virus Infection
31. Long‐term stimulation of Toll‐like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment
32. THU-204 - Nucleic Acid-Based Polymers Effective against Hepatitis B Virus Infection in Patients Do Not Harbour Immune Stimulatory Properties in Primary Isolated Blood or Liver Cells
33. THU-203 - Hepatitis B Virus Activates Toll-Like Receptor 2 Signaling upon Infection of Primary Human Hepatocytes
34. MicroRNA‐155 controls Toll‐like receptor 3‐ and hepatitis C virus‐induced immune responses in the liver
35. 347 REPETITIVE ACTIVATION OF TOLL-LIKE RECEPTOR 3 IN PRIMARY HUMAN HEPATOCYTES LEADS TO HYPER-RESPONSIVENESS TO POLY I:C IN VITRO
36. 397 THE PRO-INFLAMMATORY RESPONSE INDUCED BY TOLL-LIKE RECEPTOR ACTIVATION IN VIVO IS NOT IMPAIRED IN THE LIVER OF HBV-TRANSGENIC MICE LACKING HBsAg
37. 348 TOLL-LIKE RECEPTOR 3 STIMULATED PRIMARY HUMAN NON-PARENCHYMAL LIVER CELLS ARE POTENT SUPPRESSORS OF HEPATITIS C VIRUS REPLICATION
38. 398 VIRAL REPLICATION IN HBV-TRANSGENIC MICE LACKING THE HBsAg SIGNIFICANTLY INDUCES INTERFERON RESPONSES
39. TLR stimulated human non-parenchymal liver cells are potent suppressors of HCV replication
40. Suppression of the interferon sensitive gene 15 affects the expression of proteins that play a role in HCV replication
41. IFNs and ISGs are up-regulated in HBV-transgenic mice lacking HBsAg
42. Continuous Toll-like receptor 3 activation in primary human hepatocytes, mimicking chronic hepatitis C infection, leads to hyper-responsiveness to poly I:C in vitro
43. Activation by Pathogen- and Damage-Associated Molecular Patterns Regulates the Expression of RANTES in Primary Hepatic Stellate Cells
44. In vivo knockdown, mediated by LNP01-formulated siRNAs, of HCV pro-viral factor ISG15 increased responsiveness to Interferon
45. Hepatic, MyD88-dependent toll-like receptors are activated by in vivo application of LNP01-formulated siRNAs
46. 807 APPLICATION OF LNP01-FORMULATED SIRNAS IN VIVO ACTIVATES HEPATIC TOLL-LIKE RECEPTORS VIA MYD88-DEPENDENT PATHWAYS WHICH CAN BE CONTROLLED BY CHEMICAL RIBOSE MODIFICATIONS
47. 771 TLR3-DEPENDENT IMMUNOLOGICAL PROPERTIES OF LIVER CELLS ARE CONTROLLED BY ANTI-INFLAMMATORY CYTOKINES THROUGH MODULATION OF MIR-155 EXPRESSION
48. 814 PRIMARY HUMAN HEPATOCYTES INHIBIT EXPANSION OF VIRUS-SPECIFIC CD8+ T CELLS IN VITRO
49. 806 ISG15 SUPPRESSION IN HEPATOCYTES, MEDIATED BY LNP01-FORMULATED SIRNAS, LEADS TO ENHANCED RESPONSIVENESS TO INTERFERON IN VIVO
50. 439 HEPATITIS B VIRUS SURFACE ANTIGEN SUPPRESSES INNATE AND ADAPTIVE IMMUNE RESPONSES OF MURINE AND HUMAN LIVER CELLS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.